Patents by Inventor Matthew P. Kodrasov

Matthew P. Kodrasov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Covalent irreversible inhibitors of USP7 as anti-cancer agents
    Patent number: 10292973
    Abstract: Compounds and pharmaceutical compositions for treating cancer by, for example, modulating immune system activity, are provided.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: May 21, 2019
    Assignee: PROGENRA, Inc.
    Inventors: Joseph Weinstock, Jian Wu, Suresh Kumar Kizhakkethil-George, Feng Wang, Matthew P. Kodrasov, Saket Agarwal
  • COVALENT IRREVERSIBLE INHIBITORS OF USP7 AS ANTI-CANCER AGENTS
    Publication number: 20180228789
    Abstract: Compounds and pharmaceutical compositions for treating cancer by, for example, modulating immune system activity, are provided.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 16, 2018
    Inventors: Joseph Weinstock, Jian Wu, Suresh Kumar Kizhakkethil-George, Feng Wang, Matthew P. Kodrasov, Saket Agarwal
  • Methods of treating cancer through the inhibition of USP7 and immune system modulation
    Patent number: 9717717
    Abstract: Methods and compounds for treating cancer by, for example, modulating immune system activity, are provided.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: August 1, 2017
    Assignees: Progenra, Inc., The Children's Hospital of Philadelphia
    Inventors: Joseph Weinstock, Jian Wu, Suresh Kumar Kizhakkethil-George, Feng Wang, Matthew P. Kodrasov, Saket Agarwal, Wayne W. Hancock